Editorial
Hot topics in hepatocellular carcinoma
Translational Cancer Research
2019;
8
(Suppl 3)
:S216-S218
.
(17 April 2019)
Hot topics in cholangiocarcinoma
Translational Cancer Research
2019;
8
(Suppl 3)
:S219-S222
.
(17 April 2019)
Review Article
Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs
Translational Cancer Research
2019;
8
(Suppl 3)
:S223-S232
.
(17 April 2019)
Original Article
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma
Translational Cancer Research
2019;
8
(Suppl 3)
:S233-S244
.
(17 April 2019)
Review Article
Surgical management of hepatocellular carcinoma—Western versus Eastern attitude
Translational Cancer Research
2019;
8
(Suppl 3)
:S245-S260
.
(17 April 2019)
The future is now: beyond first line systemic therapy in hepatocellular carcinoma
Translational Cancer Research
2019;
8
(Suppl 3)
:S261-S274
.
(17 April 2019)
Cholangiocarcinoma: the quest for a second-line systemic treatment
Translational Cancer Research
2019;
8
(Suppl 3)
:S275-S288
.
(17 April 2019)
Adjuvant treatment in biliary tract cancer
Translational Cancer Research
2019;
8
(Suppl 3)
:S289-S296
.
(17 April 2019)
Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers
Translational Cancer Research
2019;
8
(Suppl 3)
:S297-S310
.
(17 April 2019)
Disclosure:
The supplement “Primary Liver Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Giovanni Brandi and Francesco Tovoli served as the unpaid Guest Editors for the supplement.
